Veterinary Vaccines Market Size to Reach USD 12.75 Billion by 2027 | Increasing Trend of Adoption of Companion Animals are Augmenting the Industry Demand, says Emergen Research

Key Veterinary Vaccines market participants include Zoetis Inc., Bayer AG, Virbac SA, Merck KGaA, Eli Lilly and Company, Phibro Animal Health Corporation, Elanco Animal Health Incorporated, Aptimmune Biologics Inc., Inc., Dechra Pharmaceuticals PLC, and Laboratorios HIPRA, S.A.


Vancouver, British Columbia, Feb. 10, 2021 (GLOBE NEWSWIRE) -- The global veterinary vaccines market is projected to reach value of USD 12.75 Billion by 2027 growing at a CAGR of 6.9%, according to a current analysis by Emergen Research. During the forecast period, the global market for veterinary vaccines is expected to expand significantly, due to the increasing demand for animal products that are safe for human consumption. Besides, the increasing trend of companion animal adoption is anticipated to propel the veterinary vaccines market further during the forecast period.

Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample-form/426

Moreover, rising application of veterinary vaccines for secure and efficient processing of food is anticipated to boost the global veterinary vaccines market in the near future. In livestock and poultry, veterinary vaccines are used to improve animal health and increase total production. In order to increase food production, more productive livestock processing and improved access to high-quality protein are required.

The lower research and development spending on veterinary vaccines is anticipated to hamper the global veterinary vaccines market to a certain extent during the forecast period.

Top Companies Profiled in Veterinary Vaccines Market Report are:

Zoetis Inc., Bayer AG, Virbac SA, Merck KGaA, Eli Lilly and Company, Phibro Animal Health Corporation, Elanco Animal Health Incorporated, Aptimmune Biologics Inc., Inc., Dechra Pharmaceuticals PLC, and Laboratorios HIPRA, S.A.

Key Highlights of Report

  • In May 2018, Abaxis, Inc. was acquired by Zoetis Inc. With this move, Zoetis would be capable to provide comprehensive solutions to its veterinary customers to foresee, avoid, diagnose, and treat diseases in animals.
  • During the forecast period, the dog segment is expected to experience growth at the most rapid pace. Increasing dog population and a rise in the mortality risk of rabies will result in a greater level of vaccination services, which would promote routine dog vaccinations. This, in turn, is likely to boost the dog segment in the near future.
  • During the forecast period, the oral segment is expected to experience substantial growth, at a CAGR of 6.9%. Improving the immunity of farm animals is the key objective of oral vaccines. Increasing demand for poultry products and high-quality meat is likely to boost the oral segment during the forecast period.
  • The toxoid segment is likely to expand significantly during the forecast period, due to advantages of toxoid vaccines, such as the low risk of infectiousness, less resistance to variability in moisture, and better stabilization.
  • The parasitic segment is likely to experience substantial growth during the forecast period. Vaccines against zoonosis and foodborne parasites are critical for improved food production, which is projected to boost the segment in the next few years.
  • The market in Asia Pacific is anticipated to witness the most rapid growth during the forecast period, rise in livestock numbers, particularly in developing nations in the region.

Check Our Prices@ https://www.emergenresearch.com/select-license/426
Emergen Research has segmented the global veterinary vaccines market in terms of type, administration path, technology, infection, and region.

  • Type Outlook (Revenue, USD Billion; 2017–2027)
    • Poultry
    • Swine
    • Aquaculture
    • Cattle
    • Cat
    • Dog
  • Administration Path Outlook (Revenue, USD Billion; 2017–2027)
    • Oral
    • Injection
    • Spray/Immersion
  • Technology Outlook (Revenue, USD Billion; 2017–2027)
    • Inactivated
    • Live Attenuated
    • Recombinant
    • Toxoid
  • Infection Outlook (Revenue, USD Billion; 2017–2027)
    • Fungal
    • Bacterial
    • Parasitic
    • Viral

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends:   https://www.emergenresearch.com/industry-report/veterinary-vaccines-market

  • Regional Outlook (Revenue, USD Billion; 2017–2027)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. India
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Take a Look at our Related Reports:

Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions

Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region

Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region

Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027

Ambulatory EHR Market By Deployment (Cloud-based, On-premises), By Practice Size (Solo Practices, Large Practices, Small-medium-sized Practices), By Application, By End-use (Independent Centers, Hospital-owned Ambulatory Centers, Others), and By Region, Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release: https://www.emergenresearch.com/press-release/global-veterinary-vaccines-market